| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Absence of host NF-κB p50 induces murine glioblastoma tumor regression, increases survival, and decreases T-cell induction of tumor-associated macrophage M2 polarization
|
Barberi, Theresa
|
|
2018
|
67 |
10 |
p. 1491-1503
|
artikel
|
| 2 |
A novel allogeneic off-the-shelf dendritic cell vaccine for post-remission treatment of elderly patients with acute myeloid leukemia
|
van de Loosdrecht, Arjan A.
|
|
2018
|
67 |
10 |
p. 1505-1518
|
artikel
|
| 3 |
Antitumor virotherapy using syngeneic or allogeneic mesenchymal stem cell carriers induces systemic immune response and intratumoral leukocyte infiltration in mice
|
Morales-Molina, Álvaro
|
|
2018
|
67 |
10 |
p. 1589-1602
|
artikel
|
| 4 |
Case report: Long-term survival of a pancreatic cancer patient immunized with an SVN-2B peptide vaccine
|
Shima, Hiroaki
|
|
2018
|
67 |
10 |
p. 1603-1609
|
artikel
|
| 5 |
Cytotoxic activity of effector T cells against cholangiocarcinoma is enhanced by self-differentiated monocyte-derived dendritic cells
|
Panya, Aussara
|
|
2018
|
67 |
10 |
p. 1579-1588
|
artikel
|
| 6 |
3-Day monocyte-derived dendritic cells stimulated with a combination of OK432, TLR7/8 ligand, and prostaglandin E2 are a promising alternative for cancer immunotherapy
|
Yi, Dag Heiro
|
|
2018
|
67 |
10 |
p. 1611-1620
|
artikel
|
| 7 |
Epidermal growth factor receptor peptide vaccination induces cross-reactive immunity to human EGFR, HER2, and HER3
|
Doyle, Hester A.
|
|
2018
|
67 |
10 |
p. 1559-1569
|
artikel
|
| 8 |
Ex vivo expanded tumour-infiltrating lymphocytes from ovarian cancer patients release anti-tumour cytokines in response to autologous primary ovarian cancer cells
|
Owens, Gemma L.
|
|
2018
|
67 |
10 |
p. 1519-1531
|
artikel
|
| 9 |
Fusobacterium nucleatum promotes M2 polarization of macrophages in the microenvironment of colorectal tumours via a TLR4-dependent mechanism
|
Chen, Ting
|
|
2018
|
67 |
10 |
p. 1635-1646
|
artikel
|
| 10 |
High-grade glioma associated immunosuppression does not prevent immune responses induced by therapeutic vaccines in combination with Treg depletion
|
Löhr, Mario
|
|
2018
|
67 |
10 |
p. 1545-1558
|
artikel
|
| 11 |
Increased antitumor activities of glypican-3-specific chimeric antigen receptor-modified T cells by coexpression of a soluble PD1–CH3 fusion protein
|
Pan, Zeyan
|
|
2018
|
67 |
10 |
p. 1621-1634
|
artikel
|
| 12 |
Older melanoma patients aged 75 and above retain responsiveness to anti-PD1 therapy: results of a retrospective single-institution cohort study
|
Ibrahim, Tony
|
|
2018
|
67 |
10 |
p. 1571-1578
|
artikel
|
| 13 |
Pilot trial of the hu14.18-IL2 immunocytokine in patients with completely resectable recurrent stage III or stage IV melanoma
|
Albertini, Mark R.
|
|
2018
|
67 |
10 |
p. 1647-1658
|
artikel
|
| 14 |
Regulatory mechanisms of PD-L1 expression in cancer cells
|
Shi, Yongyu
|
|
2018
|
67 |
10 |
p. 1481-1489
|
artikel
|
| 15 |
Safety and immunogenicity of a potential checkpoint blockade vaccine for canine melanoma
|
Kurupati, Raj K.
|
|
2018
|
67 |
10 |
p. 1533-1544
|
artikel
|
| 16 |
Safety and immunogenicity of a potential checkpoint blockade vaccine for canine melanoma
|
Kurupati, Raj K.
|
|
|
67 |
10 |
p. 1533-1544
|
artikel
|
Tijdschrift beschrijving